Sort
10,766 grants matching “checkpoint inhibitor”
Transcriptional and epigenetic mechanisms of immunotherapy resistance in melanoma
$367,559Kai W Wucherpfennig · Massachusetts General Hospital · P01 · FY2021 · CA
Role of B-cell mediated anti-tumor antibodies in responses to radiation and immunotherapy in HNSCC
$367,469Andrew B. Sharabi · University Of California, San Diego · R01 · FY2023 · DE
Project 1: Priming and propagating immunity against head and neck cancer using targeted radionuclide therapy
$367,423Zachary Scott Morris · University Of Wisconsin-Madison · P50 · FY2022 · CA
Immunotherapeutic Modalities for K-ras Mutant Lung Cancer: Sex- and Cell Type-Specific Roles of IL-6/STAT3 signaling
$367,325Seyed Javad Mirhassani Moghaddam · University Of Tx Md Anderson Can Ctr · R01 · FY2020 · CA
Tumor-intrinsic signaling pathways restrict anti-tumor immunity in hepatocellular carcinoma
$367,259Amaia Lujambio · Icahn School Of Medicine At Mount Sinai · R37 · FY2024 · CA
Role of B-cell mediated anti-tumor antibodies in responses to radiation and immunotherapy in HNSCC
$367,178Andrew B. Sharabi · University Of California, San Diego · R01 · FY2021 · DE
Regulation of p53 by TAF1
$367,135Xuan Liu · University Of California Riverside · R01 · FY2016 · CA
Discovery of Chemical Probes of SAMHD1 for Modulation of Cancer Therapy and the Immune System
$367,087James T. Stivers · Johns Hopkins University · R01 · FY2022 · CA
Discovery of Chemical Probes of SAMHD1 for Modulation of Cancer Therapy and the Immune System
$367,087James T. Stivers · Johns Hopkins University · R01 · FY2023 · CA
Role of YAP in Treg Function and YAP Targeting for Cancer Immunotherapy
$367,087Drew M. Pardoll · Johns Hopkins University · R01 · FY2022 · CA
Role of intratumoral high endothelial venules in tumor immunity
$367,087Masanobu Komatsu · Johns Hopkins University · R01 · FY2023 · CA
Role of YAP in Treg Function and YAP Targeting for Cancer Immunotherapy
$367,087Drew M. Pardoll · Johns Hopkins University · R01 · FY2023 · CA
Regulation of antigen presenting cells in the tumor microenvironment by retinoic acid
$367,066Malay Haldar · University Of Pennsylvania · R37 · FY2025 · CA
Cell cycle regulation in response to plasma membrane stress in S. cerevisae
$366,850Amy E Ikui · Brooklyn College · SC1 · FY2017 · GM
Hec1 Network as Molecular Therapeutic Targets
$366,808Wen-Hwa Lee · University Of California-Irvine · R01 · FY2010 · CA
Develop a Therapeutic Nano-vaccine against Head and Neck Cancer
$366,795Yu Leo Lei · University Of Michigan At Ann Arbor · R01 · FY2022 · DE
Replication Associated Genetic Rearrangements
$366,736Brandeis University · R01 · FY2004 · GM
Project 1: Siglec15 as a new target for lung cancer immunotherapy
$366,580Lieping Chen · Yale University · P50 · FY2024 · CA
Tumor suppressor p53 and its targets in checkpoint regulation
$366,502Sam W Lee · Massachusetts General Hospital · R01 · FY2018 · CA
Tumor suppressor p53 and its targets in checkpoint regulation
$366,502Sam W Lee · Massachusetts General Hospital · R01 · FY2017 · CA
Converting Cold to Hot Tumor Microenvironment in Prostate Cancer by Targeting Chromatin Effector
$366,441Xin Lu · University Of Notre Dame · R01 · FY2020 · CA
Development of multifunctional drug and immune modulator delivery nanoparticles for the treatment of cancer patients with comorbid atherosclerosis
$366,421Lily Yang · Emory University · R01 · FY2025 · CA
Augmenting Quadruple Negative Breast Cancer Treatment by ADRM1 Inhibitor Up284
$366,390Balasubramanyam Karanam · Tuskegee University · U54 · FY2024 · MD
Mechanism(s) of Hepatocyte Transformation by the Hepatitis B Virus X Protein
$366,384Ourania M. Andrisani · Purdue University · R01 · FY2011 · DK
Immunogenic Priming with Lu-PSMA Targeted Therapy in Advanced Prostate Cancer
$366,367Rahul Aggarwal · University Of California, San Francisco · R01 · FY2019 · CA